Analysts Viewpoint
Analysts: GILD stock price target of 126 in 12 months
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s filing revealed that its Chief Commercial Officer Mercier Johanna unloaded Company’s shares for reported $0.33 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s recent filing unveils that its Chief Commercial Officer Mercier Johanna unloaded Company’s shares for reported $0.33 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s recent filing unveils that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.1
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences,
Gilead Sciences, Inc’s recent filing unveils that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.1
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Gilead Sciences, Inc’s filing revealed that its Officer DANIEL O’DAY acquired Company’s shares for reported $1.1 million on Jun 30